MyFinsight
Home
Blog
About
Back
Income Statement
Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS)
source: myfinsight.com
Research and development
$25,280K
General and
administrative
$7,003K
Total operating
expenses
$32,283K
Loss from operations
-$28,899K
Collaboration revenue
$3,384K
Net loss
-$24,144K
Net unrealized loss
on marketable...
-$504K
Total other income,
net
$4,755K
Other expense, net
-$10K
Comprehensive loss
$24,648K
Interest income
$4,765K
Back